X0303 4 2009-10-06 0 0001405197 Talecris Biotherapeutics Holdings Corp. TLCR 0000947822 FEINBERG STEPHEN C/O CERBERUS CAPITAL MANAGEMENT, L.P. 299 PARK AVENUE - 22ND FLOOR NEW YORK NY 10171 0 0 1 0 Common Stock, par value $0.01 per share 2009-10-06 4 S 0 27052632 17.955 D 61175236 I By certain limited liability companies and limited partnerships This Form 4 is being filed in connection with the closing (the "Closing") of the initial public offering of the common stock, par value $0.01 per share (the "Common Stock"), of Talecris Biotherapeutics Holdings Corp., a Delaware corporation (the "Company"), on October 6, 2009. At the Closing, Talecris Holdings, LLC sold 27,052,632 shares of Common Stock. Immediately following the Closing, Talecris Holdings, LLC, whose managing member is Cerberus-Plasma Holdings LLC, held in the aggregate 61,175,236 shares of Common Stock. Pursuant to the Amended and Restated Limited Liability Company Agreement of Talecris Holdings, LLC, Cerberus-Plasma Holdings LLC has the authority to vote and dispose of the shares of Common Stock held by Talecris Holdings, LLC. The managing member of Cerberus-Plasma Holdings LLC is Cerberus Partners, L.P., whose general partner is Cerberus Associates, L.L.C. Stephen Feinberg is the managing member of Cerberus Associates, L.L.C. As a result of the foregoing, Mr. Feinberg, through one or more intermediate entities, possesses the sole power to vote and the sole power to direct the disposition of all securities of the Company held by Talecris Holdings, LLC. Mr. Feinberg's interest in the securities reported herein is limited to the extent of his pecuniary interest in Talecris Holdings, LLC, if any. /s/ Stephen Feinberg 2009-10-06